E2F1 and leukemia: miR-98 was found to be downregulated in the leukemia drug-resistant cell line K562/A02, and its upregulation was shown to reduce leukemia cell proliferation and enhance chemosensitivity by inhibiting E2F1 expression, highlighting the potential of miR-98 in overcoming leukemia multidrug resistance [89].